View poster as PDF
Related Content:
ASCO 2020: Results of the Randomized Phase II Study of Sipuleucel-T +/- Radium-223 in Men with Bone-Metastatic Castration-Resistant Prostate Cancer
Changing the Mechanism of Action in The Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Phillip Koo